Trial Profile
Armodafinil for Patients Starting Hepatitis C Treatment.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 13 Feb 2017
Price :
$35
*
At a glance
- Drugs Armodafinil (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- 04 May 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov
- 15 Nov 2011 New trial record